The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 and an impressive US$ 3.08 Billion by 2030.

Sanofi India denies reports of Lantus sale, calls media reports ‘unfounded’ The French pharmaceutical major has reportedly slashed the asking price for Lantus from an initial Rs 3,000 crore to ...

DELRAY BEACH, Fla., Feb. 10, 2025 /PRNewswire/ -- The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

MTD Group has completed its acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems businesses. According to the company, the acquisition is poised to increase MTD’s production ...

MILAN, Aug. 2, 2024 /PRNewswire/ -- Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems ...

According to Market.us, it is anticipated that the Pen Needles Market Size will reach approximately USD 10 billion by the year 2033. This projection indicates significant growth compared to its value ...

The global market for Pen Needles estimated at US$2.6 Billion in the year 2023, is projected to reach a revised size of US$4.8 Billion by 2030, growing at a CAGR of 8% over the analysis period ...

Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...

Pen Needles Market in terms of revenue was estimated to be worth $1.6 Billion in 2023 and is poised to reach $2.5 Billion by 2028, growing at a CAGR of 9.1% from 2023 to 2028 according to a new ...